Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Clinical Characterization of RP11 in Five Families With Identified PRPF31 Mutations

D.G. Birch; D.H. Wheaton; K.G. Locke; S.J. Bowne; L.S. Sullivan; S.P. Daiger

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1037.

ARVO Annual Meeting Abstract May 2005

Clinical Characterization of RP10 in a Large Family With an Identified (Asp226Asn) IMPDH1 Mutation

D.K. H. Wheaton; P. Kozma; G.E. Fish; K.G. Locke; S.J. Bowne; L.S. Sullivan; S.P. Daiger; D.G. Birch

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):512.

ARVO Annual Meeting Abstract May 2005

Measures of Static Perimetric Field Progression in Retinitis Pigmentosa

D.G. Birch; K.G. Locke; M. Klein; J. Felius

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):519.

ARVO Annual Meeting Abstract May 2005

Screening for Early Age–Related Macular Degeneration (AMD) Using a New Shape Discrimination Chart

Y.–Z. Wang; C.E. Wilson; K.G. Locke; B.F. Godley

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3315.

ARVO Annual Meeting Abstract May 2004

Analysis of protein haplotypes in trans as factors modifying phenotypic variation of retinal dystrophies caused by a splice site mutation in the peripherin/RDS gene

S.P. Shankar; P. Kozma; D.G. Birch; D. Hughbanks–Wheaton; K.G. Locke; R.S. Ruiz; L.S. Sullivan; S.J. Bowne; E.M. Stone; S.P. Daiger

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3719.

ARVO Annual Meeting Abstract May 2004

CLINICAL CHARACTERIZATION OF DISEASE SEVERITY AND PROGRESSION IN X–LINKED RETINITIS PIGMENTOSA (XLRP) ASSOCIATED WITH RPGR MUTATIONS:

D.K. H. Wheaton; D.G. Birch; K.G. Locke; A. Swaroop; B. Yashar; K. Haag Branham; S.J. Bowne; L.S. Sullivan; S.P. Daiger; D.R. Hoffman

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):5160.

ARVO Annual Meeting Abstract May 2004

Human mutant ELOVL4 causes retinal dystrophy in transgenic mice

K.G. Locke; G. Karan; Z. Yang; K. Zhang; D.G. Birch

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1769.

ARVO Annual Meeting Abstract May 2003

Dietary Nutrients and Yearly Rates of Decline in Retinal Function in Patients with X-linked Retinitis Pigmentosa (XLRP)

D.G. Birch; K.G. Locke; D.H. Wheaton; G.E. Fish; D.R. Hoffman

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):545.

ARVO Annual Meeting Abstract May 2003

The Relationship Between ERG Measures of Phototransduction Efficiency and Genotype in Retinitis Pigmentosa

P. Kozma-Wiebe; K.G. Locke; D.H. Wheaton; D.C. Hood; D.G. Birch

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1863.

ARVO Annual Meeting Abstract May 2003

Rapid Clinical Assessment of A-Wave Photoreceptor Function

C.R. Seaman; K.G. Locke; D.C. Hood; D.G. Birch

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1884.

ARVO Annual Meeting Abstract May 2003

Four-Year Outcomes from a Randomized Clinical Trial of Docosahexaenoic Acid (DHA) Supplementation in X-Linked Retinitis Pigmentosa (XLRP)

D.R. Hoffman; D.H. Wheaton; K.G. Locke; G.E. Fish; D.G. Birch

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4851.

Advertisement